Flerie AB (publ) (STO:FLERIE)

Sweden flag Sweden · Delayed Price · Currency is SEK
42.10
-0.25 (-0.59%)
Aug 29, 2025, 4:53 PM CET
-0.59%
Market Cap3.26B
Revenue (ttm)10.20M
Net Income (ttm)-258.60M
Shares Out77.46M
EPS (ttm)-3.31
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,449
Average Volume15,516
Open42.00
Previous Close42.35
Day's Range41.75 - 42.40
52-Week Range37.21 - 51.51
Betan/a
RSI40.11
Earnings DateOct 22, 2025

About Flerie AB

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 5
Stock Exchange Nasdaq Stockholm
Ticker Symbol FLERIE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.